Home > Products > Aprima
Share Print This Page

Aprima (Apremilast)
Therapeutic Group: Skin » Immunomodulator

Aprima 10 Tablet: Each tablet contains Apremilast INN 10 mg.

Aprima 30 Tablet: Each tablet contains Apremilast INN 30 mg.

Apremilast is an inhibitor of phosphodiesterase 4 (PDE4) enzyme specific for cyclic adenosine monophosphate (cAMP). PDE4 inhibition results in increased intracellular cAMP levels. The specific mechanism by which Apremilast exerts its therapeutic action in psoriatic arthritis patients and psoriasis patients is not well defined.
Apremilast is indicated for the treatment of adult patients with active psoriatic arthritis and moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

Dosage & Administration
The recommended initial dosage titration of Apremilast from Day 1 to Day 5 is shown below. Following the 5-day titration, the recommended maintenance dosage is 30 mg twice daily taken orally starting on Day 6. This titration is intended to reduce the gastrointestinal symptoms associated with initial therapy. Apremilast can be administered without regard to meals.

Day 1: 10 mg in morning
Day 2: 10 mg in morning and 10 mg in evening
Day 3: 10 mg in morning and 20 mg in evening
Day 4: 20 mg in morning and 20 mg in evening
Day 5: 20 mg in morning and 30 mg in evening
Day 6 and thereafter: 30 mg twice daily

Dosage adjustment in patients with severe renal impairment

Apremilast dosage should be reduced to 30 mg once daily in patients with severe renal impairment. For initial dosage titration, it is recommended that Apremilast be titrated using only the morning schedule and the evening doses be skipped.
Side Effects
The most frequently occurring side effects of Apremilast are nausea, diarrhea, and headache.

Other less frequent side effects are upper respiratory tract infection, vomiting, nasopharyngitis, abdominal pain, hypersensitivity, gastroesophageal reflux disease, dyspepsia, fatigue, decrease appetite, cough, rash, insomnia.
Treatment with Apremilast is associated with an increase in adverse reactions of depression. Patients, their caregivers and families should be advised of the need to be alert for the emergence or worsening of depression, suicidal thoughts or other mood changes and if such changes occur to contact their healthcare provider. Prescribers should carefully evaluate the risks and benefits of continuing treatment with Apremilast if such events occur.

During the controlled period of the studies in psoriatic arthritis, weight decrease between 5%-10% of body weight was reported in 10% of subjects treated with Apremilast 30 mg twice daily compared to 3.3% treated with placebo.
Apremilast is contraindicated in patients with a known hypersensitivity to Apremilast or to any of the excipients in the formulation.
Use in Pregnancy & Lactation
Pregnancy: Pregnancy Category C.
Nursing mothers: It is not known whether Apremilast or its metabolites are present in human milk; however Apremilast was detected in milk of lactating mice. Caution should be exercised when Apremilast is administered to a nursing woman.

Usage in Pediatric Patients

The safety and effectiveness of Apremilast in pediatric patients less than18 years of age have not been established.
Drug Interaction
Co-administration of strong cytochrome P450 enzyme inducer, rifampin, resulted in a reduction of systemic exposure of Apremilast. Therefore, the use of cytochrome P450 enzyme inducers (e.g., rifampin, phenobarbital, carbamazepine, phenytoin) with Apremilast is not recommended.
Commercial Packaging
Aprima 10 Tablet: Each box contains 2 Alu-PVC blister strips of 10 tablets.

Aprima 30 Tablet: Each box contains 2 Alu-PVC blister strips of 10 tablets.
Products from the same therapeutic group
Anti Bacterial
Adaben Duo Gel
Adapalene BP 0.1% & Benzoyl peroxide BP 2.5% gel
Clindacin Cream
Clindamycin 2% w/w
Clindacin lotion
Topical Lotion
Clindacin Plus Gel
Clindamycin 1.2% and Tretinoin 0.025% Gel.
Retapamulin 1% ointment
Anti Fungal
Clotrimazole 1%
Dancel Shampoo
Ketoconazole 2% shampoo
Econazole Nitrate cream and tablet.
Fluconazole 50 mg, 150 mg, 200mg capsule & Powder for Suspension
Miconazole 2% oral gel
Miconazole Nitrate BP 2% Cream.
Anti Fungal Combination
Econate Plus
Econazole Nitrate and Triamcinolone Acetonide cream
Topicazole Plus
Miconazole Nitrate and Hydrocortisone Acetate
Anti Hyperpigmenting Agent
L-Lysine hydrochloride 15% Gel
Padimate O 8%, Avobenzone 2%, Oxybenzone 3% &Titanium dioxide 2%
Hydroquinone cream
Fluocinolone acetonide 0.01%, Hydroquinone 4% and Tretinoin 0.05%
Anti Viral
Doxepin hydrochloride 5%
Itchsol cream
Pramoxine Hydrochloride and Calamine cream
Urea BP 10%
Zinc Oxide 40% w/w
Calcipotriol 0.005% Ointment
Hair Growth Inhibitor
Eflornithine Hydrochloride Monohydrate INN Cream
Hair Growth Promoter
Minoxidil topical solution 2%, 5%
Apremilast 10 mg Tablet
Tacrolimus 0.03% & 0.1%
Prevention of Keratosis
Kerasol Cream
Salicylic Acid BP
Apalene 0.1% Cream
Tazarotene 0.1% w/w cream.
Elimate Cream
Elimate Plus
Permethrin BP 5% and Crotamiton BP 10%
Steroid Combination
Betaderm N Ointment
Betamethasone 0.1% & Neomycin Sulphate 0.5%
Betamesal Scalp Lotion
Betamethasone 0.05 % & Salicylic Acid 2%
Fusidic acid & Hydrocortisone cream
Nyclobate NN
Clobetasol Propionate, Neomycin Sulphate & Nystatin Cream
Steroid Plain
Betaderm Ointment
Betamethasone 0.1%
Fluticasone Propionate Ointment
Momeson Cream
Mometasone Furoate BP 0.1% Cream
Clobetasol Propionate Cram, Ointment and Scalp Application
Halobetasol Propionate 0.05% Cream